Sartorius (OTCMKTS:SARTF) Stock Short Interest Report for October

Sartorius (OTCMKTS:SARTF) saw a large growth in short interest during the month of October. As of October 15th, there was short interest totaling 1,827 shares, a growth of 282.2% from the September 30th total of 478 shares. Approximately 0.0% of the company’s stock are short sold. Based on an average daily volume of 0 shares, the short-interest ratio is currently ∞ days.

Sartorius Stock Performance

Shares of Sartorius stock remained flat at $243.86 on Wednesday. The company’s 50-day simple moving average is $229.54 and its 200 day simple moving average is $221.81. Sartorius has a one year low of $181.58 and a one year high of $243.86. The firm has a market cap of $8.35 billion, a PE ratio of 113.42 and a beta of 0.98. The company has a quick ratio of 0.49, a current ratio of 0.95 and a debt-to-equity ratio of 0.89.

About Sartorius

Sartorius AG is a Germany-based life science company that develops and supplies equipment, technologies and services used in research, pharmaceutical development and biopharmaceutical manufacturing. Its offerings support laboratories and production facilities across the development cycle, from early-stage research and process development to commercial-scale manufacturing.

The company operates through its Lab Products & Services and Bioprocess Solutions divisions. Its products and services include laboratory instruments, balances, consumables, analytical systems, filtration technologies, bioreactors, cell culture equipment, single-use manufacturing components, software and related services.